Aniiket Sengar 15 March, 2024 Digbi Health Launches GLP-Fit Program: Expands its Precision Biology Platform to Incorporate GLP-1 based Personalized Care for Obesity PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care, Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity
Having the commercial considerations built into the research process from the beginning -- cost, supply chain, consistency -- made all the difference compared to purely academic research that might identify something impossible to commercialize
20 Urate crystals within tissues have two fates
Payers monitor modifier 25 usage patterns and may request documentation review if the rate exceeds their benchmarks
Although approval was granted by the Therapeutic Goods Administration (TGA), the manufacturer has not commenced supply of Wegovy to the Australian market